Question 1

What is Regenxbio's cost of license and royalty revenues?

Accepted Answer

Regenxbio (RGNX) reported cost of license and royalty revenues of $1.04M in Q2 2026.

Question 2

How has Regenxbio's cost of license and royalty revenues changed year-over-year?

Accepted Answer

Regenxbio's cost of license and royalty revenues decreased by 80.0% year-over-year, from $5.21M to $1.04M.

Question 3

What does cost of license and royalty revenues mean?

Accepted Answer

This metric represents the direct costs incurred to generate revenue from licensing intellectual property and royalty agreements. It typically includes payments to third-party licensors, sub-licensing fees, and other costs directly attributable to the maintenance and monetization of the company's patent portfolio. Monitoring this helps evaluate the profitability of the company's licensing business model.

Line item	Three Months Ended June 30, 2026	Three Months Ended June 30, 2025	Six Months Ended June 30, 2026	Six Months Ended June 30, 2025
Service revenue	4,178	2,894	5,481	4,857
Total revenues	108,019	21,359	114,412	110,371
Operating Expenses
Cost of license and royalty revenues	1,042	5,209	12,116	8,645
Research and development	56,086	59,500	113,425	112,587
General and administrative	21,616	19,883	42,922	40,230
Other operating expenses	12	45	48	60
Total operating expenses	78,756	84,637	168,511	161,522

Cost Of License And Royalty Revenues at other companies

Other financials

Income statement

Balance sheet

Cash flow

Valuation

Profitability

Returns & leverage

Where this comes from

FAQ

Ask your AI about Regenxbio's cost of license and royalty revenues.

Regenxbio RGNX Cost Of License And Royalty Revenues